ALS Research Forum

Could a cancer drug targeting PARPs be repurposed as a treatment for #ALS #MND? A growing number of studies @PennMedicine suggest its a possibility. ow.ly/gCgF30n37NV @LeeanneMcgurk @ShorterLab

#ICYMI Multiple therapies may be needed to treat #ALS #MND according to a new study ow.ly/GqNK30n5UFZ #MuSK #NMJ

Could a new technique help sort out the role of microglia in neurodegenerative diseases including #ALS #MND? ow.ly/R2PE30n5orj

Looking to learn more about #ALS #MND but do not have access to a science or medical library? Check out our updated list of open-access reviews of the disease ow.ly/Nktf30n54Ka

Could disease heterogeneity be due to the "shapeshifting" nature of #TDP-43 pathology? A new #FTD study @NatureNeuro suggests its a possibility. ow.ly/WahX30n4UsF #ALS #MND

Looking to present your latest findings in #ALS #MND at an upcoming scientific conference? Check out our 2019 meeting calendar! ow.ly/bk8530n4J8L #ALS #MND

Are you aiming to facilitate clinical testing of potential #ALS #MND therapies by developing strategies to reduce disease heterogeneity? Check out this upcoming funding call @JPNDeurope to support your research ow.ly/E6iz30mXOjd via @The_MRC

Could an emerging test help detect and monitor cognitive decline in neurodegenerative diseases? A new study @JAMANeuro suggests that its a possibility ow.ly/LHJi30mUutN #FTD #ALS

Researchers @MGHNeurology detect glial activation in the spinal cord in addition to the brain in people with #ALS, a key step in developing an imaging-based tool to help evaluate potential immunotherapies in #clinicaltrials #alssymp

Learn more about this emerging adaptive #clinicaltrial design by checking out this article in @JAMA_current ow.ly/rb5A30mUux1 #ALS #alssymp

Wondering how genotyping might help facilitate testing of potential therapies for #ALS #MND in the clinic? Check out this article from our archives ow.ly/nUFB50jSUqm #UNC13A #C21 #alssymp

#ICYMI A new antibody aims to tackle #C9orf72 #ALS #MND by reducing levels of the dipeptide repeat protein poly-GA ow.ly/GM5p30mTDJn #SfN18

MT @Dr_SharonB #DidYouKnow iPSC lines derived from patients with #ALS and #FTD are now available at @EBiSC_cells @ECACC? cells.ebisc.org #alssymp #3A

Learn more about emerging "organ on chip" models that aim to facilitate the development of treatments for neurodegenerative diseases including #ALS by optimizing their ability to enter the CNS ow.ly/m8tu30mTE3J #alssymp #C4

Wondering how changes in the gut could contribute to neurodegenerative diseases including #ALS? Check out this article from our archives ow.ly/OvJi30mTVnj #microbiome #C2 #alssymp

#ICYMI A new partnership sets the stage for clinical testing of the RIPK1 inhibitor #DNL747 in #ALS #MND ow.ly/E4fH30mSs4l @sanofi #necroptosis

Last chance to apply for a research grant @FondationLatran to fund your studies in #ALS #MND Abstracts due: December 6. ow.ly/NEsV30mRB7V

#ICYMI A new pig model may help scientists to further evaluate potential therapies for #ALS #MND, particularly gene therapies. ow.ly/qbyh30mRB2S

Missed the first day of the #stemcell @CellSymposia in Los Angeles, California yesterday? Check out this article from our archives ow.ly/KxWK30mQpDp #ALS #MND

Researchers debate a new strategy to tackle #ALS #MND targeting TDP-43 pathology at the 5th RNA Metabolism in Neurological Disease Conference in San Diego ow.ly/xnqz30mQoFs #stathmin2 #ASO #SfN18